Definition: Prostate-specific antigen (PSA) is a protein made by the prostate gland and found in the blood. The NCI dictionary says PSA may be higher than normal in men with prostate cancer, benign prostatic hyperplasia, or infection or inflammation of the prostate. It is measured with a simple blood test.
Increased PSA was the most common reaction in the AndroGel 1.62% trial: 11.1% vs 0% on placebo. The label counts it as a PSA above 4.0 ng/mL or an average rise of more than 0.75 ng/mL on two measurements. Xyosted reported PSA increased in 12.0% over a year. The labels say to check for prostate cancer before and during treatment.
| Label | Effect on PSA |
|---|---|
| Proscar (finasteride 5 mg) | About 50% lower within 6 months; a new baseline is set after at least 6 months |
| Avodart (dutasteride) | About 50% lower within 3 to 6 months; a new baseline is set after at least 3 months |
| Propecia (finasteride 1 mg) | Mean PSA fell from 0.7 to 0.5 ng/mL at month 12 in men aged 18 to 41 |
All three labels say any confirmed rise from the lowest PSA on treatment may signal prostate cancer and is checked, even within the normal range. Missed doses can also affect the result.
A single PSA number means little without the ones before it. Keeping every result with its date, next to when testosterone or finasteride was started, lets a clinician read the trend the labels describe.
Read more on Dose Track: What testosterone level is normal on TRT? · Finasteride guide · Dutasteride guide · Xyosted side effects